XML 29 R14.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock Options and Restricted Stock Units
12 Months Ended
Dec. 31, 2021
Stock Options and Restricted Stock Units  
Note Stock Options and Restricted Stock Units

Note 7: Stock Options and Restricted Stock Units

 

On May 23, 2014, the shareholders of the Company approved the 2014 Equity Incentive Plan (the “2014 Plan”). Under the terms of the 2014 Plan, the Company is authorized to issue incentive awards for common stock up to 200,000 shares to employees and other personnel. On June 10, 2016 and June 17, 2020, the shareholders of the Company approved an additional 200,000 and 200,000 awards, respectively, to be issued under the 2014 Plan, bringing the total number of shares to be awarded to 600,000. The awards may be in the form of incentive stock options, nonqualified stock options, restricted stock, restricted stock units and performance awards. The 2014 Plan is effective through March 31, 2024. As of December 31, 2021, there are 223,818 shares which remain to be granted under the 2014 Plan.

The following is a summary of stock options issued during the year ended December 31, 2021 and 2020:

  

 

 

Number of Options

Outstanding

 

 

Range of

Exercise Price

 

 

Weighted Average

Exercise Price

 

 

Aggregate

Intrinsic Value

 

Balance on December 31, 2019

 

 

127,563

 

 

$

6.80 – 17.40

 

 

$12.63

 

 

$142,818

 

Options granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Options exercised

 

 

(36,250)

 

7.76 – 17.40

 

 

 

12.47

 

 

 

295,921

 

Options forfeited/cancelled

 

 

(16,083)

 

9.26 – 17.40

 

 

 

15.17

 

 

 

22,682

 

Balance on December 31, 2020

 

 

75,230

 

 

$

6.80 – 17.40

 

 

$12.16

 

 

$402,275

 

Options granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Options exercised

 

 

(23,563)

 

6.80 – 17.40

 

 

 

13.01

 

 

 

267,300

 

Options forfeited/cancelled

 

 

(4,500)

 

9.26 – 13.21

 

 

 

11.45

 

 

 

62,385

 

Balance on December 31, 2021

 

 

47,167

 

 

$

6.80 – 17.40

 

 

$11.81

 

 

$832,254

 

 

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (i.e. the aggregate difference between the closing price of the Company’s common stock on December 31, 2021 and 2020 of $29.45 and $17.51, respectively, and the exercise price for in-the-money options) that would have been received by the holders if all instruments had been exercised on December 31, 2021 and 2020. As of December 31, 2021, all stock options were vested and there was not any unrecognized compensation cost related to stock options.

 

The following is a summary of unvested stock options during the year ended December 31, 2021 and 2020:

 

 

 

Number of Options

Outstanding

 

 

Weighted Average

Exercise Price

 

 

Weighted Average Grant Date Fair Value

 

Balance on December 31, 2019

 

 

29,000

 

 

$12.87

 

 

$5.47

 

Options vested

 

 

(14,500)

 

 

12.87

 

 

 

5.47

 

Options forfeited/cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Balance on December 31, 2020

 

 

14,500

 

 

$12.87

 

 

$5.47

 

Options vested

 

 

(14,500)

 

 

12.87

 

 

 

5.47

 

Options forfeited/cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Balance on December 31, 2021

 

 

-

 

 

$

-

 

 

$

-

 

 

The following table summarizes information about stock options outstanding and exercisable on December 31, 2021:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise Price Range

 

Number

 

 

Weighted Average Remaining Contractual Life (in Years)

 

 

Weighted Average Exercise Price

 

 

Number

 

 $0.01 - 7.00 

 

 

5,000

 

 

 

3.89

 

 

$6.80

 

 

 

5,000

 

 $7.01 - 8.00

 

 

10,000

 

 

 

1.74

 

 

$7.76

 

 

 

10,000

 

 $8.01 - 12.00 

 

 

3,667

 

 

 

5.45

 

 

$10.07

 

 

 

3,667

 

 $12.01 - 15.00

 

 

20,500

 

 

 

6.61

 

 

$13.13

 

 

 

20,500

 

 $15.01 - 17.40

 

 

8,000

 

 

 

6.42

 

 

$17.40

 

 

 

8,000

 

 Total 

 

 

47,167

 

 

 

5.16

 

 

$11.81

 

 

 

47,167

 

Of the 47,167 stock options outstanding, 21,000 are non-qualified stock options. All options have been registered with the SEC.

 

There were no common stock options issued during the years ended December 31, 2021 and 2020. 

 

The following is a summary of restricted stock units issued during the years ended December 31, 2021 and 2020:

 

 

 

Number of RSUs Outstanding

 

 

Weighted Average Grant Date

Fair Value

 

 

Aggregate Intrinsic Value

 

Balance on December 31, 2019

 

 

48,002

 

 

$11.55

 

 

$554,388

 

Units granted

 

 

18,000

 

 

 

10.67

 

 

 

192,060

 

Units vested/issued

 

 

(32,002)

 

 

11.61

 

 

 

353,948

 

Units forfeited

 

 

(15,000)

 

 

11.35

 

 

 

156,665

 

Balance on December 31, 2020

 

 

19,000

 

 

$10.78

 

 

$332,690

 

Units granted

 

 

17,765

 

 

 

25.92

 

 

 

460,504

 

Units vested/issued

 

 

(19,000)

 

 

10.78

 

 

 

464,400

 

Units forfeited

 

 

-

 

 

 

-

 

 

 

-

 

Balance on December 31, 2021

 

 

17,765

 

 

$25.92

 

 

$523,197

 

   

During the year ended December 31, 2021, the Company granted 17,765 restricted stock units with a grant date fair value of $25.92 per share to certain employees and non-employee members of the Board of Directors of the Company. Non-employee directors were granted 12,765 restricted stock units, which vest on the earlier of the 2022 annual meeting of the shareholders or one year. The other 5,000 restricted stock units were granted to an employee and vest 50% during each of the first and second anniversary dates of the date of grant, which was May 17, 2021. During the year ended December 31, 2021, 19,000 restricted stock units with a grant date fair value of $10.78 vested. As of December 31, 2021, there was $234,000 of unrecognized compensation cost related to unvested restricted stock units, which will be recognized through 2023. All restricted stock units have been registered with the SEC.

 

During the years ended December 31, 2021 and 2020, the Company recorded compensation expense of $333,000 and $273,000, respectively, related to stock options and restricted stock units.

 

 Note 8: Leases

 

Generally, leasing activity consists of office leases. In March 2019, a new lease was signed to move the corporate headquarters to Raleigh, North Carolina. The new lease, which had a lease commencement date of October 2, 2019, expires December 31, 2027. Minimum lease payments are $2,997,000, not including a tenant improvement allowance of $488,000, which is included in fixed assets as of December 31, 2021 and 2020. The Company recognized a ROU asset and corresponding lease liability of $2,596,000, which represents the present value of minimum lease payments discounted at 3.77%, the Company’s incremental borrowing rate at lease inception.

  

As of December 31, 2021, the Company had a three-year office lease in Florida. This lease was signed on January 4, 2019, at which time a ROU asset and corresponding lease liability was recognized of $125,000, which represents the present value of minimum lease payments discounted at 4.25%, the Company’s incremental borrowing rate at lease inception. This lease subsequently ended on January 3, 2022 and was not renewed. The Company also has facilities in Salt Lake City, Utah, and New York, which are on short-term leases that are less than twelve months. As a result, the Company elected the short-term lease recognition exemption for these leases, which means, for those leases not expected to extend beyond twelve months, the Company will not recognize ROU assets or lease liabilities.

 

Lease liabilities totaled $2,017,000 and $2,361,000 as of December 31, 2021 and 2020, respectively. The current portion of this liability of $358,000 is included in Accrued expenses on the Consolidated balance sheets and the long-term portion of $1,659,000 is included in Lease liabilities on the Consolidated Balance Sheets. Rent expense consists of both operating lease expense from amortization of ROU assets as well as variable lease expense which consists of non-lease components of office leases (i.e. common area maintenance) or rent expense associated with short- term leases. The components of lease expense were as follows (in 000’s):

 

 

Year ended

December 31,

2021

 

 

Year ended

December 31,

2020

 

Lease expense

 

 

 

 

 

 

Operating lease expense

 

$347

 

 

$347

 

Variable lease expense

 

 

116

 

 

 

132

 

Rent expense

 

$463

 

 

$479

 

 

The weighted-average remaining non-cancelable lease term for operating leases was 6.0 years as of December 31, 2021. As of December 31, 2021, the weighted-average discount rate used to determine the lease liability was 3.77%. The future minimum lease payments to be made under non-cancelable operating leases on December 31, 2021, are as follows (in 000’s):

 

Year Ended December 31:

 

 

 

2022

 

$359

 

2023

 

 

369

 

2024

 

 

379

 

2025

 

 

389

 

2026

 

 

399

 

Thereafter

 

 

413

 

Total lease payments

 

$2,308

 

Present value adjustment

 

 

(291)

Lease liability

 

 

2,017

 

 

The Company performed an evaluation of other contracts with customers and suppliers in accordance with Topic 842 and have determined that, except for the leases described above, none of the contracts contain a lease.